Clinical trial
Effectiveness of Pimozide in Augmenting the Effects of Clozapine in the…
NCT00158223 · Icahn School of Medicine at Mount Sinai, Other · Completed
Key facts
| NCT number | NCT00158223 |
|---|---|
| Title | Effectiveness of Pimozide in Augmenting the Effects of Clozapine in the Treatment of Schizophrenia |
| Official title | Pimozide Augmentation of Clozapine in Schizophrenia |
| Lead sponsor | Icahn School of Medicine at Mount Sinai, Other |
| Collaborators | National Institute of Mental Health (NIMH) NIH |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Schizophrenia, Psychotic Disorders |
| Intervention type | Drug |
| Interventions | Pimozide, Placebo |
| Enrollment | 76 |
| Start date | Oct 1, 2004 |
| Primary completion | Feb 1, 2009 |
| Completion | Feb 1, 2009 |
| First posted | Sep 12, 2005 |
| Last update posted | Apr 9, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: